Current Liabilities

Deferred Revenue

Medtronic Deferred Revenue increased by 33.3% to $400.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $400.00M to $400.00M. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ3 2015
Last reportedQ4 2025

How to read this metric

An increase suggests strong sales of subscription-based services or bundled offerings, providing a predictable pipeline for future revenue recognition.

Detailed definition

Represents cash payments received from customers in advance of the company fulfilling its performance obligations, speci...

Peer comparison

High-growth software and services companies typically maintain larger deferred revenue balances relative to pure hardware manufacturers.

Metric ID: deferred_revenue_current

Historical Data

15 periods
 Q2 '21Q3 '21Q4 '21Q2 '22Q3 '22Q4 '22Q2 '23Q3 '23Q4 '23Q2 '24Q3 '24Q4 '24Q2 '25Q3 '25Q4 '25
Value$1.20B$1.10B$1.00B$801.00M$719.00M$662.00M$600.00M$500.00M$500.00M$400.00M$400.00M$400.00M$400.00M$300.00M$400.00M
QoQ Change-8.3%-9.1%-19.9%-10.2%-7.9%-9.4%-16.7%+0.0%-20.0%+0.0%+0.0%+0.0%-25.0%+33.3%
YoY Change-33.3%-34.6%-33.8%-25.1%-30.5%-24.5%-33.3%-20.0%-20.0%+0.0%-25.0%+0.0%
Range$300.00M$1.20B
CAGR-26.9%
Avg YoY Growth-23.3%
Median YoY Growth-25.0%

Frequently Asked Questions

What is Medtronic's deferred revenue?
Medtronic (MDT) reported deferred revenue of $400.00M in Q4 2025.
How has Medtronic's deferred revenue changed year-over-year?
Medtronic's deferred revenue decreased by 0.0% year-over-year, from $400.00M to $400.00M.
What does deferred revenue mean?
Money collected from customers for products or services that haven't been delivered yet but will be within a year.